New Brain Treatment Gives Parkinson's Patients Lasting Relief

Patients with advanced Parkinson's disease now have a powerful new treatment option that doesn't require a single incision.

Doctors at Delray Medical Center in Florida helped lead a major clinical trial proving that focused ultrasound therapy can dramatically reduce Parkinson's motor symptoms for at least 12 months. The results, published in The Lancet Neurology in July 2026, show patients experienced relief within just one month of treatment.

Dr. Arif Dalvi, a neurologist at Delray Medical Center, co-authored the study alongside neurosurgeon Dr. Lloyd Zucker. Their hospital enrolled more patients than any other site nationwide, contributing directly to FDA approval of the treatment.

The therapy uses targeted sound waves guided by MRI imaging to treat specific brain areas linked to Parkinson's symptoms. No surgical cuts, no implanted devices, just precise waves of sound reaching exactly where they're needed.

"This publication represents years of dedication to improving the lives of patients living with Parkinson's disease," Dr. Dalvi said. The treatment offers hope specifically for patients whose symptoms no longer respond well to medication.

The multicenter trial followed people with advanced Parkinson's and motor complications. After receiving staged bilateral magnetic resonance-guided focused ultrasound, patients showed significant improvement in motor function and fewer disease-related complications.

The Ripple Effect

Delray Medical Center's leadership in this research extends far beyond its own patients. By enrolling more participants than any other hospital in the nation, the Florida team accelerated the path to FDA approval, meaning Parkinson's patients across America can now access this less invasive option.

The hospital continues advancing neurological care through clinical trials for conditions including Alzheimer's disease. "Serving as the leading enrollment site in the nation demonstrates our commitment to advancing medicine and expanding access to innovative treatments," said Delray Medical Center CEO Heather Havericak.

Dr. Zucker emphasized the personal reward of offering patients effective treatment while shaping the future of Parkinson's care. For the estimated one million Americans living with Parkinson's disease, this research represents real progress toward better quality of life.

The study confirms that focused ultrasound isn't just effective in the short term but provides durable relief that lasts, giving patients and their families renewed hope for managing this challenging condition.